Literature DB >> 31147062

Co-culture of human umbilical vein endothelial cells and human bone marrow stromal cells into a micro-cavitary gelatin-methacrylate hydrogel system to enhance angiogenesis.

Jian Liu1, Yon Jin Chuah1, Jiayin Fu1, Wenzhen Zhu1, Dong-An Wang2.   

Abstract

Vascular tissue engineering seeks to develop functional blood vessels that comprise of both endothelial cells and pericytes for translational medicine and is often faced with numerous challenges such as nutrients and wastes diffusion problem in the centre of the scaffolds. Various strategies have been adopted to solve the diffusion problem in thick engineered scaffolds. Typically, microchannels or dissolvable microspheres are introduced into three-dimensional (3D) scaffolds as an alternative way to improve the infiltration of scaffolds and endothelial cells are usually incorporated into the biomaterials. While some research groups now focus on finding supporting cells to build further vascularized structures in the scaffolds. In this study, a bioinspired 3D gelatin-methacrylate (Gel-MA) hydrogel with dissolvable microspheres was created to encapsulate human bone marrow stromal cells (HMSCs) and human umbilical vein endothelial cells (HUVECs) which was used to investigate whether HMSCs could play a pericytes-like role and enhance vascularization within the engineered scaffolds. The results showed co-culture of HMSCs and HUVECs demonstrated significantly improved vascularization when compared to either HUVECs or HMSCs monoculture. Angiogenic genes were expressed significantly higher in co-culture group. Moreover, when implanting the pre-vascularized scaffolds in vivo, co-culture system integrated more successfully with host tissue and showed higher host tissue invasion than any other groups. More importantly, both the qPCR and immunofluorescence results indicated MSCs differentiated towards pericytes to enhance vascularization in this study. This paper highlights the enhanced capability of 3D micro-cavitary Gel-MA hydrogel for co-culturing HUVECs and HMSCs to promote vascularization which presents a potential strategy for future tissue repair and regeneration.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coculture; Gelatin methacrylate microcavity hydrogel; Human bone marrow stromal cells; Vascularization

Mesh:

Substances:

Year:  2019        PMID: 31147062     DOI: 10.1016/j.msec.2019.04.089

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  5 in total

1.  Co-growth of Stem Cells With Target Tissue Culture as an Easy and Effective Method of Directed Differentiation.

Authors:  Marina Valentinovna Kovina; Tatyana Gennadievna Dyuzheva; Mikhail Evgenievich Krasheninnikov; Sergey Alexandrovich Yakovenko; Yury Mikhailovich Khodarovich
Journal:  Front Bioeng Biotechnol       Date:  2021-06-16

2.  Ginsenoside Compound K Enhances Fracture Healing via Promoting Osteogenesis and Angiogenesis.

Authors:  Lingli Ding; Song Gu; Bingyu Zhou; Min Wang; Yage Zhang; Siluo Wu; Hong Zou; Guoping Zhao; Zhao Gao; Liangliang Xu
Journal:  Front Pharmacol       Date:  2022-04-01       Impact factor: 5.988

3.  In vitro dynamic perfusion of prevascularized OECs-DBMs (outgrowth endothelial progenitor cell - demineralized bone matrix) complex fused to recipient vessels in an internal inosculation manner.

Authors:  Zhian Chen; Dixin Cai; Rongmao Shi; Wei Ding; Yongqing Xu; Hongbo Tan
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

4.  Synthetic Extracellular Matrices for 3D Culture of Schwann Cells, Hepatocytes, and HUVECs.

Authors:  Chiyuan Ma; Kaizheng Liu; Qin Li; Yue Xiong; Cuixiang Xu; Wenya Zhang; Changshun Ruan; Xin Li; Xiaohua Lei
Journal:  Bioengineering (Basel)       Date:  2022-09-08

Review 5.  Angiogenesis in Tissue Engineering: As Nature Intended?

Authors:  Valeria Mastrullo; William Cathery; Eirini Velliou; Paolo Madeddu; Paola Campagnolo
Journal:  Front Bioeng Biotechnol       Date:  2020-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.